Cytotoxic cerebral edema
Citation, DOI & article data
The term is frequently used in clinical practice to denote the combination of true cytotoxic edema and ionic cerebral edema. As the pathophysiology of these two types of edema is different, as is their imaging, they are discussed separately. The remainder of this article is concerned with true cytotoxic edema, also known as cellular edema 8.
Cytotoxic edema is the result of cells being unable to maintain ATP-dependent sodium/potassium (Na+/K+) membrane pumps which are responsible for high extracellular and low intracellular Na+ concentration 6. When energy fails, as is the case in cerebral ischemia, these pumps cease to operate and Na+ accumulates within the cell, drawing with it chloride (Cl-) and water along an osmotic gradient. This, in turn, results in cellular swelling and a reduction in the extracellular volume 9. These are the primary reasons for increased restricted diffusion on MRI.
This intracellular edema mainly affects grey matter but also involves the white matter as astrocytes are also involved.
In true isolated cytotoxic edema little change is evident on CT as a mere redistribution of water from extracellular to intracellular compartments does not result in attenuation changes. The changes colloquially ascribed to 'cytotoxic edema' are in fact mostly due to ionic edema and are described separately. This is why brain CT is often normal in patients with an acute ischemic stroke.
As cytotoxic edema represents the redistribution of water from extracellular to intracellular compartments, without a change in local constituents it stands to reason that no T1 or T2 changes are evident. As is the case with CT, the changes colloquially ascribed to 'cytotoxic edema' are in fact mostly due to ionic edema and are described separately.
The one sequence which is able to identify cytotoxic edema, and was thus responsible for a revolution in the imaging of acute ischemic stroke, is diffusion weighted imaging (DWI). As cells swell due to inward shift of water, there is a commensurate decrease in diffusion, identified as high signal on DWI and low signal on ADC.
These changes persist into the subacute phase until about two weeks when the ADC signal begins to rise above the normal parenchyma and eventually becomes hyperintense.
Treatment and prognosis
Treatment generally focuses on the underlying cause of cerebral edema. Steroids are not beneficial in the treatment of cytotoxic edema secondary to stroke, and may, in fact, be harmful in cytotoxic edema from trauma 7.
- 1. Na DG, Kim EY, Ryoo JW et-al. CT sign of brain swelling without concomitant parenchymal hypoattenuation: comparison with diffusion- and perfusion-weighted MR imaging. Radiology. 2005;235 (3): 992-48. Radiology (full text) - doi:10.1148/radiol.2353040571 - Pubmed citation
- 2. Koch S, Rabinstein A, Falcone S et-al. Diffusion-weighted imaging shows cytotoxic and vasogenic edema in eclampsia. AJNR Am J Neuroradiol. 2001;22 (6): 1068-70. AJNR Am J Neuroradiol (full text) - Pubmed citation
- 3. Kallenberg K, Bailey DM, Christ S et-al. Magnetic resonance imaging evidence of cytotoxic cerebral edema in acute mountain sickness. J. Cereb. Blood Flow Metab. 2006;27 (5): 1064-71. doi:10.1038/sj.jcbfm.9600404 - Pubmed citation
- 4. Ho ML, Rojas R, Eisenberg RL. Cerebral edema. AJR Am J Roentgenol. 2012;199 (3): W258-73. doi:10.2214/AJR.11.8081 - Pubmed citation
- 5. Stadnik TW, Demaerel P, Luypaert RR et-al. Imaging tutorial: differential diagnosis of bright lesions on diffusion-weighted MR images. Radiographics. 23 (1): e7. doi:10.1148/rg.e7 - Pubmed citation
- 6. Simard JM, Kent TA, Chen M et-al. Brain oedema in focal ischaemia: molecular pathophysiology and theoretical implications. Lancet Neurol. 2007;6 (3): 258-68. doi:10.1016/S1474-4422(07)70055-8 - Free text at pubmed - Pubmed citation
- 7. Neurology Emergencies. Oxford University Press. ISBN:0195388585. Read it at Google Books - Find it at Amazon
- 8. Liang D, Bhatta S, Gerzanich V, Simard JM. Cytotoxic edema: mechanisms of pathological cell swelling. (2007) Neurosurgical focus. 22 (5): E2. doi:10.3171/foc.2007.22.5.3 - Pubmed
- 9. Michinaga S & Koyama Y. Pathogenesis of Brain Edema and Investigation into Anti-Edema Drugs. IJMS. 2015;16(12):9949-75. doi:10.3390/ijms16059949 - Pubmed